Clinical Trial Update: IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on the IoN- study assessing whether ablative radio-iodine is necessary for low-risk differentiated thyroid cancer, spanning Phase 2 and Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Drugs mentioned

• Iodine-131 (Iodine-131)

Snippet

Sponsor: University College, London | Conditions: Thyroid Cancer | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING